Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
0.8209
-0.1084 (-11.66%)
At close: Jun 27, 2025, 4:00 PM
0.8260
+0.0051 (0.62%)
After-hours: Jun 27, 2025, 7:54 PM EDT

Lexicon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
298267373360587481
Upgrade
Market Cap Growth
-71.81%-28.50%3.58%-38.55%21.91%9.11%
Upgrade
Enterprise Value
210114261255480391
Upgrade
Last Close Price
0.750.741.531.913.943.42
Upgrade
PS Ratio
8.348.59310.102593.281968.6220.05
Upgrade
PB Ratio
2.201.834.013.085.163.08
Upgrade
P/TBV Ratio
3.802.637.694.978.504.30
Upgrade
EV/Sales Ratio
6.713.68216.721833.751610.5116.31
Upgrade
Debt / Equity Ratio
0.860.731.140.470.020.08
Upgrade
Asset Turnover
0.090.120.010.000.000.08
Upgrade
Inventory Turnover
234.90274.50----
Upgrade
Quick Ratio
2.195.345.425.973.923.26
Upgrade
Current Ratio
2.225.445.606.084.023.37
Upgrade
Return on Equity (ROE)
-86.09%-167.66%-168.50%-88.37%-65.01%-42.84%
Upgrade
Return on Assets (ROA)
-28.88%-43.77%-50.24%-37.91%-31.95%-34.85%
Upgrade
Return on Capital (ROIC)
-33.06%-51.20%-57.29%-43.56%-38.19%-40.63%
Upgrade
Earnings Yield
-59.47%-75.07%-47.44%-28.28%-14.96%-12.17%
Upgrade
FCF Yield
-56.50%-67.36%-43.49%-25.02%-15.04%-29.73%
Upgrade
Buyback Yield / Dilution
-48.45%-44.73%-33.42%-13.79%-31.41%5.06%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q